C. Dohna-Schwake, MD; R. Ragette, MD; U. Mellies, MD; V. Straub, MD; H. Teschler, MD; and T. Voit, MD Congenital muscular dystrophies (CMDs) are a heterogenous group of autosomal recessively inherited muscle disorders. Laminin ␣2 negative CMD (MDC1A) constitutes approximately 40% of all CMD in the white population. A number of muscular dystrophies with secondary loss of laminin ␣2 are known, including Fukuyama CMD, MDC1B, MDC1C, and muscle-eye-brain disease. Patients with limb-girdle muscular dystrophy (LGMD 2I) have different mutations in the same gene as MDC1C but have a milder clinical course. Other forms of CMD with normal expression of laminin ␣2 have been identified at the molecular level, including CMD with rigid spine (RSMD-1) and Ullrich CMD. Despite rapid progress in classification, many patients with a phenotype of CMD do not match to any of the described forms.
Methods. We performed a prospective respiratory assessment of 23 patients with CMD and 4 patients with LGMD 2I from 1998 to 2001. Patients had a full diagnostic workup including muscle immunohistochemistry and additional molecular studies according to the criteria of the European project of genetic resolution of CMD (GENRE). 5 The final diagnosis of two patients with a rigid spine syndrome remained unknown. They were included because of similar clinical features to RSMD-1 patients. Patients with LGMD 2I were included because of secondary laminin deficiency and mutations in the same gene as MDC1C.
Spirometry (inspiratory vital capacity [IVC] ) and respiratory muscle pressures (peak inspiratory pressure [PIP] , peak expiratory pressure [PEP] ) were used to assess respiratory function in 24 patients. Daytime blood gases (PaCO 2 , PaO 2 ) were obtained in all patients, and polysomnography including transcutaneous carbon dioxide tension (P tc CO 2 ) was obtained in all but one.
Results. Five patients presented with diurnal hypercapnic respiratory failure (diurnal hypoventilation group). Daytime PaCO 2 (56.3 Ϯ 4.6 mm Hg) aggravated during sleep to a maximum P tc CO 2 of 74.0 Ϯ 9.6 mm Hg.
In 10 patients with normal PaCO 2 of 40.9 ϫ 2.6 mm Hg, polysomnography revealed hypoventilation during REM sleep alone or during all sleep stages (nocturnal hypoventilation group). Total sleep time with P tc CO 2 Ͼ50 mm Hg was 41.7 Ϯ 36.4%. No hypoventilation, either nocturnal (mean P tc CO 2 , 41.7 Ϯ 2.5 mm Hg) or diurnal (mean PaCO 2 , 36.5 Ϯ 2.3 mm Hg), was diagnosed in 12 patients (normal ventilation group). IVC was highest in the normal ventilation group (67.6 Ϯ 25.1%) and decreased stepwise to the nocturnal (27.3 Ϯ 8.8%) and diurnal (21.4 Ϯ 8.4%) hypoventilation group (p Ͻ 0.001).
Nocturnal and diurnal gas exchange correlated with IVC (figure) and to a lesser degree with PIP (mean nocturnal saturation: R ϭ 0.44, p Ͻ 0.05; PaCO 2 : R ϭ Ϫ0.71, p Ͻ 0.001; PaO 2 : R ϭ 0.46, p Ͻ 0.05) and PEP (mean nocturnal saturation: R ϭ 0.61, p Ͻ 0.005; PaCO 2 : R ϭ Ϫ0.58, p Ͻ 0.005; PaO 2 : R ϭ 0.61, p Ͻ 0.005).
In patients with primary laminin ␣2 deficiency, seven wheelchair-bound patients showed either diurnal or nocturnal hypoventilation, whereas three ambulant patients had normal blood gases. This clear relation was also observed in patients with secondary laminin ␣2 deficiency. Four ambulant patients had IVCs between 76 and 110% compared with wheelchair-bound patients with restrictive ventilatory defect (31%, 34%) and associated REM hypoventilation and REM hypopneas. The patients with RSMD-1 or CMD with rigid spine were all ambulant, but two had nocturnal hypoventilation and two had daytime respiratory failure.
Elevated P tc CO 2 during sleep was measured in two patients (one was still ambulant) with Ullrich CMD.
Discussion. We performed a systematic evaluation of respiratory function in CMD and LGMD 2I patients. They showed a high prevalence of respiratory dysfunction. Fourteen individuals (52%) had either nocturnal or diurnal hypoventilation. Because patients had been referred for the purpose of routine evaluation, this prevalence rate is likely to be representative of CMD collectives in general, but a bias toward more severely affected patients cannot be ruled out.
Respiratory failure and nocturnal hypoventilation have been reported in different CMD cases. 6 In addition, our data show a direct relationship between IVC, the index measure of ventilatory restriction, and the presence and severity of hypoventilation. Ninety-three percent of hypoventilation occurred in patients with IVC Ͻ40%, confirming a recently established threshold for hypoventilation. 7 We also found a clear relationship between motor capacities and respiratory function in patients with primary and secondary laminin ␣2 deficiency. All three ambulant patients showed normal gas exchange compared with 1 of 12 wheelchair-bound patients. Considerable asynchrony in peripheral and respiratory muscle involvement occurred in other CMD subgroups, exemplified by the fact that all patients with RSMD-1, one patient with the rigid spine syndrome, and one with Ullrich CMD had hypoventilation but were still ambulant.
Respiratory failure and nocturnal hypoventilation are frequent complications of CMD. If IVC is Ͻ40%, a sleep study should be performed. In patients with MDC1A, RSMD-1, and MDC1C, we recommend earlier evaluation of nocturnal gas exchange.
Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after L-P shunt

A. McGonigal, MRCP; I. Bone, FRCP; and E. Teasdale, FRCR
The pathophysiology of idiopathic intracranial hypertension (IIH) is poorly understood. A recent MRI study of sinovenous stenoses showed a high prevalence of transverse sinus stenoses in patients with IIH compared with a control population. 1 However, it remains unclear whether these appearances represent a cause or a consequence of IIH. 2 The following case report illustrates radiologically the changing morphology of the cerebral venous sinuses associated with a case of treated IIH.
Case report. A 19-year-old woman presented with a 2-week history of headache, blurred vision, and diplopia. One week before onset of headache she had taken oral penicillin for 2 days for a presumed right ear infection. Medical history was unremarkable, and she was on no medication; in particular, she had never taken the oral contraceptive pill, vitamin A supplements, or tetracycline.
On examination, she was overweight (body mass index, 27), normotensive (104/57 mm Hg), and had bilateral 6th cranial nerve palsies, severe bilateral papilledema, reduced visual acuity (VA) (6/9 on right, 6/24 on left), and markedly constricted visual fields with impaired color vision. There were no other neurologic findings.
Unenhanced CT and MRI of brain were normal. Lumbar puncture on the day of admission revealed an elevated CSF opening pressure of 67 cm (normal Ͻ20) with normal CSF constituents. CT venography performed the following day demonstrated severe narrowing of both distal transverse sinuses with no evidence of intracranial venous sinus thrombosis (figure, A). 3 Electrolytes, calcium levels, and full blood count were normal.
A diagnosis of IIH was made. After lumbar puncture, a transient improvement in headache and VA was noted (6/5 on right, 6/12 on left). Oral acetazolamide (500 mg twice daily) was initiated. On day 4, because of worsening headache, a second lumbar puncture was performed, showing an opening pressure of 63 cm with normal constituents.
Vision deteriorated further (VA 6/6 on right, 6/36 on left), and retinal edema and hemorrhages appeared. Lumbar CSF pressure monitoring was performed, showing pressures of 30 to 50 mm Hg and multiple "B" waves. Risk of permanent visual loss resulted in emergency lumbar-peritoneal shunt insertion on day 6. Visual function improved (VA 6/9 on the right, 6/18 on the left) within 48 hours, with improvement in papilledema and color vision. She developed postural headaches indicative of a low CSF pressure state.
CT venogram was repeated 6 days after shunt insertion and showed a marked reduction in the degree of transverse sinus narrowing bilaterally (figure, B). The patient was discharged headache-free with improved visual function (VA 6/9 on right and 6/12 on left).
Discussion. Manometric studies have shown a venous pressure gradient between the proximal and distal segments of the transverse sinus in patients with IIH 4 disappearing when the CSF pressure is reduced by cervical puncture. 5 The effect on venous sinus caliber of acutely decreasing CSF pressure has not been previously demonstrated using CT venography. Our findings illustrate and support the hypothesis that increased intracranial pressure (ICP) can cause collapse of the walls of the transverse sinus. 5 This transmural gradient may exacerbate increased ICP by causing a functional venous outflow obstruction. When CSF pressure is then decreased, the walls of the venous sinus are allowed to expand, and the venous pressure gradient decreases acutely.
Attempts to treat IIH patients with transverse venous stenoses by stenting have reported improved symptoms and signs in some, although this observation does not exclude venous stenosis simply being a secondary effect of increased ICP. 6, 7 The intricate relationship between increased ICP and venous sinus outflow obstruction remains to be elucidated.
Validation of intracerebral hemorrhage scores for patients with pontine hemorrhage
Oscar H. Del Brutto, MD; and Xavier Campos, MD
The optimal therapy for intracerebral hemorrhages (ICHs) remains uncertain.
1,2 A first step for reaching a consensus on management is the development of grading scales, such as the ICH score, that allow risk stratification of ICH patients. 3 This scale was later modified to improve the prediction of functional recovery among survivors of ICH. 4 Such studies included patients with hemorrhages at various locations, and it is unknown whether these scales are reliable predictors of outcome in patients with brainstem hemorrhages. We tested the validities of the original and the modified ICH score in patients with pontine hemorrhages.
Patients and methods. We prospectively evaluated 62 consecutive patients with a pontine hemorrhage admitted to our institutions from January 1997 to December 2001. The following information was recorded for each patient: age, sex, stroke risk factors, NIH Stroke Scale (NIHSS), Glasgow Coma Scale (GCS), modified Rankin Scale (mRS), and neuroimaging findings.
We applied the original and the modified ICH score to our patients using cutoff values identical to those used by others. 3, 4 The original ICH score is composed of five items: GCS score (2 points for scores of 3 or 4, 1 point for scores of 5 to 12, and 0 point for scores of 13 to 15), age (1 point for patients Ն80 years and 0 point for Ͻ80 years), ICH volume (1 point for hemorrhages Ն30 mL and 0 point for those Ͼ30 mL), ventricular blood (1 point), and infratentorial bleeding (1 point). 3 In the modified ICH score, the NIHSS is used instead of the GCS, but the other items remain unchanged. The modified ICH score assigns 2 points for patients with NIHSS scores Ն21, 1 point for those with scores of 11 to 20, and 0 point for those with scores Յ10. Results. The patients were 42 men and 20 women with a mean age of 52 Ϯ 16.2 years. Six patients were Ն80 years. On admission, 19 patients had GCS scores of 13 to 15, 17 had GCS scores of 5 to 12, and 26 had GCS scores of 3 or 4. On the NIHSS, 7 patients had scores Յ10, 14 had scores of 11 to 20, and 41 had scores Ն21. Twenty-five patients had ventricular blood, and the volume of the hematoma was Ͻ30 mL in all cases. Using the original ICH score, we found that 18 patients had 1 point, 10 had 2 points, 16 had 3 points, 14 had 4 points, and 4 had 5 points. In the modified ICH score, 7 patients had 1 point, 12 had 2 points, 19 had 3 points, 19 had 4 points, and 5 had 5 points. No patient had 0 or 6 points in either the original or the modified ICH scores because all had infratentorial hemorrhages (1 point) and all hematomas were Ͻ30 mL (0 point). The overall 30-day mortality rate was 48.4% (30 patients). Among the survivors, 22 patients had a good outcome (mRS ϭ 0 to 2), and 10 were left with disabling sequelae (mRS ϭ 3 to 5) 1 month after the bleeding.
The original ICH score was designed to predict the risk of mortality among patients with ICH. 3 Therefore, we only evaluated the relationship between the score and mortality. We found 30-day mortality rates of 0%, 30%, 62.5%, 92.8%, and 100% for patients with 1, 2, 3, 4, and 5 points, respectively. Using a cutoff value of Ն3 points for mortality (as in the original publication 3 ), this score had a sensitivity of 90% (95% CI ϭ 74.4 to 96.5%), a specificity of 78.1% (95% CI ϭ 61.2 to 89%), a positive predictive value of 79.4% (95% CI ϭ 63.2 to 89.7%), and a negative predictive value of 89.3% (95% CI ϭ 72.8 to 96.3%). When we evaluated the relationship between the modified ICH score and mortality, we found 30-day mortality rates of 0% for patients with 1 and 2 points and of 57.8%, 73.7%, and 100% for those with 3, 4, and 5 points, respectively. Using a similar cutoff value of Ն3 points for
Figure. Thirty-day outcome in patients with pontine hemorrhage using the original (top) and the modified (bottom) intracerebral hemorrhage scores.
mortality, the modified ICH score had a sensitivity of 98.4% (95% CI ϭ 86.3 to 99.8%), a specificity of 59.1% (95% CI ϭ 42.2 to 74%), a positive predictive value of 69.3% (95% CI ϭ 54.6 to 80.9%), and a negative predictive value of 97.5% (95% CI ϭ 80 to 99.7%). A good outcome (mRS Ͻ2) was noted in 100%, 83.3%, 21.1%, 5.3%, and 0% for patients with 1, 2, 3, 4, and 5 points, respectively. Using a cutoff value of 2 points for good outcome (as in the original publication 4 ), the modified ICH score had a sensitivity of 77.3% (95% CI ϭ 56.6 to 89.9%), a specificity of 95% (95% CI ϭ 83.5 to 98.6%), a positive predictive value of 88.4% (95% CI ϭ 75.5 to 94.9%), and a negative predictive value of 89.5% (95% CI ϭ 68.6 to 97.1%).
Discussion. Because in this series all patients had hemorrhages Ͻ30 mL, ICH scores only reflected patient age, stroke severity, and the presence of intraventricular blood; the other components could not be evaluated. ICH scores are accurate for predicting mortality in patients with pontine hemorrhages (figure) . In our patients, the original and modified ICH scores had similar sensitivities, specificities, and positive and negative predictive value for mortality. The modified ICH score has the advantage of being a good instrument for predicting the outcome among survivors of the bleeding episode. We found similar figures to those reported, validating these findings and providing evidence that these scores are helpful for the evaluation of patients with infratentorial bleeding. 3, 4 Specific hypothalamic activation during a spontaneous cluster headache attack
T. Sprenger, MD; H. Boecker, MD; T.R. Tolle, MD, PhD; G. Bussone, MD; A. May, MD; and M. Leone, MD
Cluster headache, the most severe pain condition among the primary headache syndromes, is characterized by unilateral excruciating head pain and autonomic dysfunction. 1 Functional neuroimaging has recently improved the pathophysiologic understanding of the different primary headache syndromes. Thereby, brainstem activation was found in migraine, 2, 3 and hypothalamic overactivity was observed in nitrate-induced cluster headache 4 and in short-lasting, unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT). 5 Results of voxel-based morphometry support the role of the posterior hypothalamus in the pathogenesis of cluster headache because an increased gray matter density has been shown in this structure. 6 However, the cluster headache attacks investigated so far were triggered with nitroglycerin (NTG). Although clinical and experimental data show NTG-provoked and spontaneous cluster attacks to be comparable and NTG does not alter regional cerebral blood flow (rCBF) significantly, 4 the vasoactive properties of nitrates have to be considered, and data from spontaneous cluster attacks are desirable to confirm the mentioned results. We present a case of a spontaneous cluster attack during an ongoing H 2
15
O-PET study.
Case report. A man (aged 30 years, right-handed, no medication) with a 2-year history of chronic cluster headache and no history or family history of migraine was imaged using H 2 15 O-PET. He underwent stereotactic electrode implantation for deep brain stimulation of the left posterior hypothalamus 2 months earlier. 7 After the surgery, the patient had occasional cluster attacks with identical features to preoperative attacks but at lower frequency. The last attack before the scanning occurred 48 hours earlier and was treated with sumatriptan injection. Because the original study goal was to identify stimulation effects on brain activity, the deep brain stimulator was either switched "on" or "off " during these scans. Switching the stimulator on or off for a short duration has never induced headache attacks thus far. The patient gave written informed consent, and the study was approved by the local ethics committee and conducted in accord with the Declaration of Helsinki.
Our patient had a spontaneous attack during the last 30 minutes of the study while the stimulator was inactive (visual analog scale ratings increased from 8 to 10 during these 30 minutes).
Three H 2 15
O-PET scans of 90 seconds each were obtained during this period on an ECAT EXACT HRϩ Scanner (CTI, Knoxville, TN). Before this episode, four scans with the stimulator switched off were acquired. After attenuation correction and reconstruction (filtered backprojection), all images were realigned, transformed into standard stereotactic space, and smoothed (Gaussian kernel with 10 mm full-width at half maximum, SPM99, London, UK). A comparison of pain and pain-free scans was conducted (p Ͻ 0.001). Based on the previously published data in nitrate-induced cluster headache, activations of the inferior hypothalamic gray matter, thalamus, anterior cingulate cortex (ACC), and bilateral insulae were hypothesized, and small volume correction using the false Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the discovery rate approach (p Ͻ 0.05) was applied on each of these regions (spherical volumes of interest with a radius of 10 mm surrounding the activation center). 4 The cluster headache attack induced activation increases (pain Ͼ no pain) in the ipsilateral hypothalamus (figure), medial thalamus, and contralateral perigenual ACC (all p Ͻ 0.001, corrected for multiple comparisons using small volume correction) (see table E-1 on the Neurology Web site).
A statistical trend toward activation was observed in the periaqueductal gray matter (PAG) (see figure) , but no small volume correction was performed for this brain structure because there is no literature thus far supporting a role of the PAG in cluster headache. An activation trend of the bilateral insulae was observed when increasing the threshold to p Ͻ 0.005, without being significant after small volume correction.
Discussion. We present PET data of a spontaneous cluster headache attack, revealing an activation pattern comparable with that observed in nitrate-induced cluster headache. 4 The role of the posterior hypothalamus as pathophysiologically relevant structure in the generation of cluster headache could be confirmed with an hypothalamic activation overlapping the one previously published. 4 The observed trend of brainstem activation points to a more general activation of this brain structure in pain and headache instead of being specific to migraine, 3 but further research is needed. In view of our results, it appears unlikely that previous imaging data on this disease were confounded by NTG. Furthermore, the previous imaging studies were based on group comparisons (i.e., significant differences were detected when data of multiple patients were averaged across subjects). We were able to show abnormalities in an individual patient and therefore to underline the paradigm shift in the pathophysiologic concept of primary headache syndromes. This emphasizes that cluster headache is not a primarily vascular disorder and that primary headache syndromes can be distinguished on a functional neuroanatomic basis by areas of activation specific to the clinical presentation. OXC ϭ oxcarbazepine; LEV ϭ levetiracetam; MTS ϭ mesial temporal sclerosis; VPA ϭ valproic acid; TPM ϭ topiramate; LOR ϭ lorazepam; CAR ϭ carbamazepine; DPH ϭ diphenytoin; PB ϭ phenobarbital; Crb ϭ cerebellar; ZNM ϭ zonisamide; GAB ϭ gabapentin; TGB ϭ tiagabine; PMD ϭ primidone; Bi ϭ bilateral; LMT ϭ lamotrigine.
